TAPSE/TRV tertiles | |||
---|---|---|---|
Characteristic | Low (N = 359) | Middle (N = 359) | High (N = 359) |
TAPSE/TRV ratio | 4.73 (3.81, 5.38) | 6.92 (6.44, 7.46) | 9.78 (8.83, 11.04) |
Age (years) | 73 (64, 79) | 70 (60, 78) | 63 (52, 73) |
Sex | |||
 Female | 189 (53%) | 191 (53%) | 191 (53%) |
 Male | 170 (47%) | 168 (47%) | 168 (47%) |
APACHE 3 score | 72 (58, 88) | 65 (51, 86) | 62 (46, 80) |
(Missing) | 12 | 11 | 5 |
Medical/Surgical | |||
 Medical | 322 (90%) | 314 (87%) | 298 (83%) |
 Surgical | 37 (10%) | 45 (13%) | 61 (17%) |
Invasive ventilation | |||
 Not ventilated | 187 (52%) | 180 (50%) | 174 (48%) |
 Ventilated | 172 (48%) | 179 (50%) | 185 (52%) |
APACHE comorbidities | |||
 Cirrhosis | 10 (2.8%) | 12 (3.3%) | 13 (3.6%) |
 Chronic respiratory disease | 62 (17%) | 48 (13%) | 38 (11%) |
 Chronic cardiovascular disease | 45 (13%) | 26 (7.2%) | 5 (1.4%) |
 Chronic renal disease | 18 (5.0%) | 18 (5.0%) | 7 (1.9%) |
 Immunosuppressed | 57 (16%) | 64 (18%) | 47 (13%) |
 Hepatic failure | 2 (0.6%) | 1 (0.3%) | 0 (0%) |
 Metastatic cancer | 9 (2.5%) | 13 (3.6%) | 13 (3.6%) |
ICU length of stay (days) | 3.7 (2.1, 7.2) | 3.8 (2.1, 7.0) | 3.8 (1.9, 7.9) |
ICU outcome | |||
 Died | 71 (20%) | 58 (16%) | 41 (11%) |
 Survived | 288 (80%) | 301 (84%) | 318 (89%) |
Hospital length of stay (days) | 12 (6, 22) | 11 (6, 22) | 11 (6, 27) |
(Missing) | 2 | 6 | 1 |
Hospital outcome | |||
 Died | 109 (30%) | 83 (23%) | 59 (16%) |
 Survived | 249 (70%) | 274 (77%) | 300 (84%) |
 (Missing) | 1 | 2 | 0 |
Long-term outcome | |||
 Dead | 253 (70%) | 207 (58%) | 159 (44%) |
 Survived | 106 (30%) | 152 (42%) | 200 (56%) |